BAUSCH + LOMB CORP

NYSE: BLCO (Bausch + Lomb Corporation)

Last update: 4 days ago, 11:33PM

21.09

-0.05 (-0.24%)

Previous Close 21.14
Volume 524,940
Price / Earnings (Forward) 18.34
Price / Sales 1.39
Price / Book 1.17
52 Weeks Range
14.44 (-31%) — 21.40 (1%)
Profit Margin -7.50%
Operating Margin (TTM) -5.36%
Diluted EPS (TTM) -1.02
Quarterly Revenue Growth (YOY) 3.50%
Total Debt/Equity (MRQ) 75.07%
Current Ratio (MRQ) 1.56
Operating Cash Flow (TTM) 166.00 M
Levered Free Cash Flow (TTM) 69.00 M
Return on Assets (TTM) 0.61%
Return on Equity (TTM) -5.36%

AIStockmoo Score

1.3
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Valuation History info NA
Low debt. Weak profitability. Positive cash flow. info
Return on Capital info NA
From our AI technical analysis of the chart. info NA
No clear trend over the past year. Trading near its 52-week high. info
In an uptrend: the price is above its moving averages, and they are rising. It has risen well above them. Volume is heavier on up days. info
Candle Patterns info NA
Above its medium-term trend line. info
No recent price targets, so based on how targets have been revised. info
Recent news mostly positive. info
Insider Activity info NA
Institutions net -0.28% of shares in their latest 13F filings: 60 holders increased, 35 decreased (quarter to 30 Sep 2026). info
Market environment cautious. info
Sector outperforming the market.
The pillars agree, so the score is strengthened.
Price is high against its 52-week average. info
Trend up on all three terms. Short-term momentum rising. info
Price is near resistance. info
Final Score 1.34
Show all

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Mixed Mixed
Medical Instruments & Supplies (Global) Mixed Mixed
Stock Bausch + Lomb Corporation Mixed Bullish

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BLCO - - - 1.17
RMD - 1.08% - 5.66
BDX - 2.20% - 2.41
WST - 0.37% - 9.67
ALC - 0.49% - 1.64
STVN - 0.30% - 2.39

Select this tab to load the latest available analysis.

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Mid Core
% Held by Insiders 88.13%
% Held by Institutions 10.97%

Ownership

Name Date Shares Held
Caspian Capital Lp 30 Jun 2026 1,999,043
Glenview Capital Management, Llc 30 Jun 2026 1,918,148
Clark Estates Inc/Ny 30 Sep 2026 881,000

No data within this time range.

No data within this time range.

Institutions

Institutional ownership: 10.66%

Positions Holders Shares
Increased 60 5,333,667
Decreased 35 5,694,076
New 24 1,736,083
Sold out 9 2,368,991

SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.

7 Positive 0 Negative 2 Neutral
Date Type Details
14 Nov 2026 Yahoo Finance Bausch + Lomb (BLCO) Following Its Rally Is Fair Value Still In Sight
Bausch + Lomb (BLCO) has been drawing attention after recent trading, with the share price last closing at US$21.09. The move sits against a recent pattern of mixed short term and longer term returns. Over the past month, Bausch + Lomb has seen a sharp shift in momentum, with a 31.48% 30 day share…
13 Nov 2026 Yahoo Finance Bausch + Lomb (BLCO) Stock Still Looks Undervalued Despite Its 35% Run
Bausch + Lomb shares have moved higher in recent months, which puts a sharper spotlight on whether the current US$21.09 price lines up with the cash flows the business can realistically generate. After a solid stretch for the stock, the key issue for anyone looking at Bausch + Lomb today is how…
13 Nov 2026 Yahoo Finance Best Growth Stocks to Buy for November 13th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 13, 2026…
11 Nov 2026 Yahoo Finance Best Growth Stocks to Buy for November 11th
BLCO, VLO, and HAS it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2026…
06 Nov 2026 Yahoo Finance Zacks.com featured highlights include Repsol, Bausch + Lomb, DMC Global, Universal Logistics and Methanex
Repsol, Bausch + Lomb and three other stocks show strong relative price strength, rising earnings estimates and potential for further gains.
05 Nov 2026 Yahoo Finance Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great Choice
Does Bausch + Lomb (BLCO) have what it takes to be a top stock pick for momentum investors? Let's find out.
04 Nov 2026 Yahoo Finance Bausch + Lomb: 3 Key Takeaways for Long-Term Investors
Premium product adoption is lifting margins faster than revenue growth, a sign of pricing power in a competitive market.
04 Nov 2026 Yahoo Finance Why Bausch + Lomb (BLCO) Might be Well Poised for a Surge
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
03 Nov 2026 Yahoo Finance BLCO vs. HQY: Which Stock Is the Better Value Option?
BLCO vs. HQY: Which Stock Is the Better Value Option?

Technical Setup Medium

Trend order
Slope
Entry
Volume
In an uptrend: the price is above its moving averages, and they are rising. It has risen well above them. Volume is heavier on up days.
Nearest support: 19.36 – 19.84 · moderate level
Nearest resistance: 21.20 – 21.56 · moderate level

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria